Human Engineer in United States

Pfizer US/PR Commercial Sales Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Sales Organization Mission & Impact Pfizer’s Rare Disease – Rare Cardiac Sales organization exists to help improve the lives of people living with serious rare cardiac conditions by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need— advancing disease and product education grounded in robust clinical evidence , promoting Pfizer Rare Cardiac therapies compliantly, and supporting healthcare professionals’ understanding of appropriate patient identification and use based on approved indications. Through evidence‑based scientific exchange, we help reduce access, diagnostic, and workflow barriers so more patients can start and stay on the right therapy. Our impact is more informed clinical decision ‑ making, improved consistency of care, and better outcomes for patients , contributing to a higher standard of care across the rare cardiac community. Role Summary The Rare Disease – Rare Cardiac, Senior Health & Science Specialist is a field-based specialty sales role responsible for driving the growth of Rare Cardiac products through compliant, strategic relationships within assigned accounts. This role par

Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Hemophilia Sales Organization Mission & Impact Pfizer’s Rare Disease – Hemophilia Sales organization exists to help improve the lives of people living with hemophilia by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need—promoting Pfizer Hemophilia therapies compliantly, helping customers understand appropriate use, and reducing access and care coordination barriers so more patients can start and stay on the right therapy. Our impact is better, more consistent outcomes for patients and a higher standard of care across the hemophilia community. Patient impact in rare disease: Support appropriate diagnosis, referral to Hemophilia Treatment Centers (HTCs) where applicable, initiation, and persistence by engaging hematologists, HTC multidisciplinary teams, and allied care partners involved in bleeding disorder management. Disease education grounded in evidence: Reinforce evidence-based value narratives using approved materials to support informed clinical decision-making in hemophilia. Coordinated care pathways & access: Partner across the matrix and with HTCs, specialty pharmacies, payers, and ancillary sites to simplify starts, reimbursement navigation, and continuity

Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Hemophilia Sales Organization Mission & Impact Pfizer’s Rare Disease – Hemophilia Sales organization exists to help improve the lives of people living with hemophilia by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need—promoting Pfizer Hemophilia therapies compliantly, helping customers understand appropriate use, and reducing access and care coordination barriers so more patients can start and stay on the right therapy. Our impact is better, more consistent outcomes for patients and a higher standard of care across the hemophilia community. Patient impact in rare disease: Support appropriate diagnosis, referral to Hemophilia Treatment Centers (HTCs) where applicable, initiation, and persistence by engaging hematologists, HTC multidisciplinary teams, and allied care partners involved in bleeding disorder management. Disease education grounded in evidence: Reinforce evidence-based value narratives using approved materials to support informed clinical decision-making in hemophilia. Coordinated care pathways & access: Partner across the matrix and with HTCs, specialty pharmacies, payers, and ancillary sites to simplify starts, reimbursement navigation, and continuity

🚀 About WRITER WRITER is where the world's leading enterprises orchestrate AI-powered work. Our vision is to expand human capacity through superintelligence. And we're proving it's possible – through powerful, trustworthy AI that unites IT and business teams together to unlock enterprise-wide transformation. With WRITER's end-to-end platform, hundreds of companies like Mars, Marriott, Uber, and Vanguard are building and deploying AI agents that are grounded in their company's data and fueled by WRITER's enterprise-grade LLMs. Valued at $1.9B and backed by industry-leading investors including Premji Invest, Radical Ventures, and ICONIQ Growth, WRITER is rapidly cementing its position as the leader in enterprise generative AI. Founded in 2020 with office hubs in San Francisco, New York City, Seattle, Austin, Chicago, and London, our team thinks big and moves fast, and we're looking for smart, hardworking builders and scalers to join us on our journey to create a better future of work with AI. 📐 About the role We are looking for a visionary and execution-oriented AI transformation lead to serve as a high-impact partner for our most strategic Fortune 100 accounts. In this role, you’ll be the architect of change, moving beyond simple software implementation to help the world's largest organizations fundamentally rethink how they work. You’ll sit at the intersection of business strategy and cutting-edge technology, translating the power of the WRITER platform into measurable P&L impact and helping executives navigate the shift to an AI-first operating model. This is a rare opportunity to build the playbook for enterprise AI transformation. You won’t just be managing accounts; you’ll be driving the next industrial revolution by helping C-suite leaders move from AI experimentation to full-scale value realization. Your work will directly influence WRITER's product roadmap and help define how the world’s biggest brands use superintelligence to expand human capacity. Thi

🚀 About WRITER WRITER is where the world's leading enterprises orchestrate AI-powered work. Our vision is to expand human capacity through superintelligence. And we're proving it's possible – through powerful, trustworthy AI that unites IT and business teams together to unlock enterprise-wide transformation. With WRITER's end-to-end platform, hundreds of companies like Mars, Marriott, Uber, and Vanguard are building and deploying AI agents that are grounded in their company's data and fueled by WRITER's enterprise-grade LLMs. Valued at $1.9B and backed by industry-leading investors including Premji Invest, Radical Ventures, and ICONIQ Growth, WRITER is rapidly cementing its position as the leader in enterprise generative AI. Founded in 2020 with office hubs in San Francisco, New York City, Seattle, Austin, Chicago, and London, our team thinks big and moves fast, and we're looking for smart, hardworking builders and scalers to join us on our journey to create a better future of work with AI. 📐 About the role We are looking for a visionary and execution-oriented AI transformation lead to serve as a high-impact partner for our most strategic Fortune 100 accounts. In this role, you’ll be the architect of change, moving beyond simple software implementation to help the world's largest organizations fundamentally rethink how they work. You’ll sit at the intersection of business strategy and cutting-edge technology, translating the power of the WRITER platform into measurable P&L impact and helping executives navigate the shift to an AI-first operating model. This is a rare opportunity to build the playbook for enterprise AI transformation. You won’t just be managing accounts; you’ll be driving the next industrial revolution by helping C-suite leaders move from AI experimentation to full-scale value realization. Your work will directly influence WRITER's product roadmap and help define how the world’s biggest brands use superintelligence to expand human capacity. Thi

🚀 About WRITER WRITER is where the world's leading enterprises orchestrate AI-powered work. Our vision is to expand human capacity through superintelligence. And we're proving it's possible – through powerful, trustworthy AI that unites IT and business teams together to unlock enterprise-wide transformation. With WRITER's end-to-end platform, hundreds of companies like Mars, Marriott, Uber, and Vanguard are building and deploying AI agents that are grounded in their company's data and fueled by WRITER's enterprise-grade LLMs. Valued at $1.9B and backed by industry-leading investors including Premji Invest, Radical Ventures, and ICONIQ Growth, WRITER is rapidly cementing its position as the leader in enterprise generative AI. Founded in 2020 with office hubs in San Francisco, New York City, Seattle, Austin, Chicago, and London, our team thinks big and moves fast, and we're looking for smart, hardworking builders and scalers to join us on our journey to create a better future of work with AI. 📐 About the role We are looking for a visionary and execution-oriented AI transformation lead to serve as a high-impact partner for our most strategic Fortune 100 accounts. In this role, you’ll be the architect of change, moving beyond simple software implementation to help the world's largest organizations fundamentally rethink how they work. You’ll sit at the intersection of business strategy and cutting-edge technology, translating the power of the WRITER platform into measurable P&L impact and helping executives navigate the shift to an AI-first operating model. This is a rare opportunity to build the playbook for enterprise AI transformation. You won’t just be managing accounts; you’ll be driving the next industrial revolution by helping C-suite leaders move from AI experimentation to full-scale value realization. Your work will directly influence WRITER's product roadmap and help define how the world’s biggest brands use superintelligence to expand human capacity. Thi

🚀 About WRITER WRITER is where the world's leading enterprises orchestrate AI-powered work. Our vision is to expand human capacity through superintelligence. And we're proving it's possible – through powerful, trustworthy AI that unites IT and business teams together to unlock enterprise-wide transformation. With WRITER's end-to-end platform, hundreds of companies like Mars, Marriott, Uber, and Vanguard are building and deploying AI agents that are grounded in their company's data and fueled by WRITER's enterprise-grade LLMs. Valued at $1.9B and backed by industry-leading investors including Premji Invest, Radical Ventures, and ICONIQ Growth, WRITER is rapidly cementing its position as the leader in enterprise generative AI. Founded in 2020 with office hubs in San Francisco, New York City, Seattle, Austin, Chicago, and London, our team thinks big and moves fast, and we're looking for smart, hardworking builders and scalers to join us on our journey to create a better future of work with AI. 📐 About the role We are looking for a visionary and execution-oriented AI transformation lead to serve as a high-impact partner for our most strategic Fortune 100 accounts. In this role, you’ll be the architect of change, moving beyond simple software implementation to help the world's largest organizations fundamentally rethink how they work. You’ll sit at the intersection of business strategy and cutting-edge technology, translating the power of the WRITER platform into measurable P&L impact and helping executives navigate the shift to an AI-first operating model. This is a rare opportunity to build the playbook for enterprise AI transformation. You won’t just be managing accounts; you’ll be driving the next industrial revolution by helping C-suite leaders move from AI experimentation to full-scale value realization. Your work will directly influence WRITER's product roadmap and help define how the world’s biggest brands use superintelligence to expand human capacity. Thi

🚀 About WRITER WRITER is where the world's leading enterprises orchestrate AI-powered work. Our vision is to expand human capacity through superintelligence. And we're proving it's possible – through powerful, trustworthy AI that unites IT and business teams together to unlock enterprise-wide transformation. With WRITER's end-to-end platform, hundreds of companies like Mars, Marriott, Uber, and Vanguard are building and deploying AI agents that are grounded in their company's data and fueled by WRITER's enterprise-grade LLMs. Valued at $1.9B and backed by industry-leading investors including Premji Invest, Radical Ventures, and ICONIQ Growth, WRITER is rapidly cementing its position as the leader in enterprise generative AI. Founded in 2020 with office hubs in San Francisco, New York City, Seattle, Austin, Chicago, and London, our team thinks big and moves fast, and we're looking for smart, hardworking builders and scalers to join us on our journey to create a better future of work with AI. 📐 About the role We are looking for a visionary and execution-oriented AI transformation lead to serve as a high-impact partner for our most strategic Fortune 100 accounts. In this role, you’ll be the architect of change, moving beyond simple software implementation to help the world's largest organizations fundamentally rethink how they work. You’ll sit at the intersection of business strategy and cutting-edge technology, translating the power of the WRITER platform into measurable P&L impact and helping executives navigate the shift to an AI-first operating model. This is a rare opportunity to build the playbook for enterprise AI transformation. You won’t just be managing accounts; you’ll be driving the next industrial revolution by helping C-suite leaders move from AI experimentation to full-scale value realization. Your work will directly influence WRITER's product roadmap and help define how the world’s biggest brands use superintelligence to expand human capacity. Thi

🚀 About WRITER WRITER is where the world's leading enterprises orchestrate AI-powered work. Our vision is to expand human capacity through superintelligence. And we're proving it's possible – through powerful, trustworthy AI that unites IT and business teams together to unlock enterprise-wide transformation. With WRITER's end-to-end platform, hundreds of companies like Mars, Marriott, Uber, and Vanguard are building and deploying AI agents that are grounded in their company's data and fueled by WRITER's enterprise-grade LLMs. Valued at $1.9B and backed by industry-leading investors including Premji Invest, Radical Ventures, and ICONIQ Growth, WRITER is rapidly cementing its position as the leader in enterprise generative AI. Founded in 2020 with office hubs in San Francisco, New York City, Seattle, Austin, Chicago, and London, our team thinks big and moves fast, and we're looking for smart, hardworking builders and scalers to join us on our journey to create a better future of work with AI. 📐 About the role We are looking for a visionary and execution-oriented AI transformation lead to serve as a high-impact partner for our most strategic Fortune 100 accounts. In this role, you’ll be the architect of change, moving beyond simple software implementation to help the world's largest organizations fundamentally rethink how they work. You’ll sit at the intersection of business strategy and cutting-edge technology, translating the power of the WRITER platform into measurable P&L impact and helping executives navigate the shift to an AI-first operating model. This is a rare opportunity to build the playbook for enterprise AI transformation. You won’t just be managing accounts; you’ll be driving the next industrial revolution by helping C-suite leaders move from AI experimentation to full-scale value realization. Your work will directly influence WRITER's product roadmap and help define how the world’s biggest brands use superintelligence to expand human capacity. Thi

🚀 About WRITER WRITER is where the world's leading enterprises orchestrate AI-powered work. Our vision is to expand human capacity through superintelligence. And we're proving it's possible – through powerful, trustworthy AI that unites IT and business teams together to unlock enterprise-wide transformation. With WRITER's end-to-end platform, hundreds of companies like Mars, Marriott, Uber, and Vanguard are building and deploying AI agents that are grounded in their company's data and fueled by WRITER's enterprise-grade LLMs. Valued at $1.9B and backed by industry-leading investors including Premji Invest, Radical Ventures, and ICONIQ Growth, WRITER is rapidly cementing its position as the leader in enterprise generative AI. Founded in 2020 with office hubs in San Francisco, New York City, Seattle, Austin, Chicago, and London, our team thinks big and moves fast, and we're looking for smart, hardworking builders and scalers to join us on our journey to create a better future of work with AI. 📐 About the role Writer is the enterprise AI platform for agentic work, purpose-built for the Fortune 500 — and our platform is expanding fast. As a product marketing lead, you'll own the go-to-market strategy for new products and features in our Core app, helping prospects understand how WRITER empowers marketing and sales teams to transform their work, and driving new feature adoption among current customers. You'll sit at the intersection of product, sales, and marketing — translating complex platform capabilities into crisp messaging that resonates with enterprise buyers. 🦸🏻‍♀️ What you’ll do Own end-to-end product marketing for WRITER Agent and other key features of our core app, including positioning, messaging, launch strategy, and competitive differentiation – translating new agentic capabilities into clear enterprise value Partner with product, demand generation, content, comms, and customer marketing teams to drive go-to-market for product and feature launches Trans

About Flexport: At Flexport, we believe global trade can move the human race forward. That’s why it’s our mission to make global commerce so easy there will be more of it. We’re shaping the future of a $10T industry with solutions powered by innovative technology and exceptional people. Today, companies of all sizes—from emerging brands to Fortune 500s—use Flexport technology to move more than $19B of merchandise across 112 countries a year. The recent global supply chain crisis has put Flexport center stage as we continue to play a pivotal role in how goods move around the world. We are proud to have the support of the best investors in the game who believe in our mission, solutions and people. Ready to tackle global challenges that impact business, society, and the environment? Come join us. You will: Drive all things ocean carrier procurement for a particular tradelane and take direct responsibility for one or multiple carriers Coordinate and negotiate annual, quarterly, monthly, and weekly allocation procurement activities Help decide the global carrier strategy and align your tradelane’s carrier strategy to help the global team hit their goals Help develop long term partnerships with ocean carriers, demonstrating Flexport’s competitive advantages Drive procurement costs down Provide supply forecasting so that we ensure we can satisfy demand Build scalable procurement operating rhythms and tools Partner with Technology teams to develop next generation procurement systems Drive process standardization and improvement initiatives globally Educate and enable the broader Flexport organization with carrier and tradelane intelligence to foster better decision making and client engagement Manage a team of procurement associates that will drive initiatives Lead regular cross team meetings Initiate system and process improvements for the team Up-level the future ocean procurement experts of Flexport Work across Procurement, Pricing, Planning

About Flexport: At Flexport, we believe global trade can move the human race forward. That’s why it’s our mission to make global commerce so easy there will be more of it. We’re shaping the future of a $10T industry with solutions powered by innovative technology and exceptional people. Today, companies of all sizes—from emerging brands to Fortune 500s—use Flexport technology to move more than $19B of merchandise across 112 countries a year. The recent global supply chain crisis has put Flexport center stage as we continue to play a pivotal role in how goods move around the world. We are proud to have the support of the best investors in the game who believe in our mission, solutions and people. Ready to tackle global challenges that impact business, society, and the environment? Come join us. You will: Drive all things ocean carrier procurement for a particular tradelane and take direct responsibility for one or multiple carriers Coordinate and negotiate annual, quarterly, monthly, and weekly allocation procurement activities Help decide the global carrier strategy and align your tradelane’s carrier strategy to help the global team hit their goals Help develop long term partnerships with ocean carriers, demonstrating Flexport’s competitive advantages Drive procurement costs down Provide supply forecasting so that we ensure we can satisfy demand Build scalable procurement operating rhythms and tools Partner with Technology teams to develop next generation procurement systems Drive process standardization and improvement initiatives globally Educate and enable the broader Flexport organization with carrier and tradelane intelligence to foster better decision making and client engagement Manage a team of procurement associates that will drive initiatives Lead regular cross team meetings Initiate system and process improvements for the team Up-level the future ocean procurement experts of Flexport Work across Procurement, Pricing, Planning

Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Sales Organization Mission & Impact Pfizer’s Rare Disease – Rare Cardiac Sales organization exists to help improve the lives of people living with serious rare cardiac conditions by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need— advancing disease and product education grounded in robust clinical evidence , promoting Pfizer Rare Cardiac therapies compliantly, and supporting healthcare professionals’ understanding of appropriate patient identification and use based on approved indications. Through evidence‑based scientific exchange, we help reduce access, diagnostic, and workflow barriers so more patients can start and stay on the right therapy. Our impact is more informed clinical decision ‑ making, improved consistency of care, and better outcomes for patients , contributing to a higher standard of care across the rare cardiac community. Role Summary The Rare Disease – Rare Cardiac, Senior Health & Science Specialist is a field-based specialty sales role responsible for driving the growth of Rare Cardiac products through compliant, strategic relationships within assigned accounts. This role partners with Therapeutic Area Specialists and Key

Pfizer US/PR Commercial Sales Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Sales Organization Mission & Impact Pfizer’s Rare Disease – Rare Cardiac Sales organization exists to help improve the lives of people living with serious rare cardiac conditions by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need— advancing disease and product education grounded in robust clinical evidence , promoting Pfizer Rare Cardiac therapies compliantly, and supporting healthcare professionals’ understanding of appropriate patient identification and use based on approved indications. Through evidence‑based scientific exchange, we help reduce access, diagnostic, and workflow barriers so more patients can start and stay on the right therapy. Our impact is more informed clinical decision ‑ making, improved consistency of care, and better outcomes for patients , contributing to a higher standard of care across the rare cardiac community. Role Summary The Rare Disease – Rare Cardiac, Senior Health & Science Specialist is a field-based specialty sales role responsible for driving the growth of Rare Cardiac products through compliant, strategic relationships within assigned accounts. This role partn

Pfizer US/PR Commercial Sales Founded in 1849, Pfizer Inc. began as a small chemistry enterprise built on the belief that scientific ingenuity can improve—and protect—human life. Today, as one of the world’s leading biopharmaceutical companies, Pfizer’s purpose is Breakthroughs that change patients’ lives : discovering, developing, and delivering medicines and vaccines that address unmet need, earn trust through quality and integrity, and reach patients through strong partnerships across the healthcare system. In a complex and rapidly evolving pharmaceutical landscape, our work is measured by one outcome - helping patients live longer, healthier lives . Rare Disease Sales Organization Mission & Impact Pfizer’s Rare Disease – Rare Cardiac Sales organization exists to help improve the lives of people living with serious rare cardiac conditions by connecting scientific innovation to the clinicians and systems that deliver care. We lead with integrity and patient need— advancing disease and product education grounded in robust clinical evidence , promoting Pfizer Rare Cardiac therapies compliantly, and supporting healthcare professionals’ understanding of appropriate patient identification and